SH2 domains: modulators of nonreceptor tyrosine kinase activity

Current Opinion in Structural Biology

Volumn 19, Issue 6, 2009, Pages 643-649

  Filippakopoulos, Panagis ^a   Müller, Susanne ^a   Knapp, Stefan ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; PROTEIN SH2; PROTEIN TYROSINE KINASE;

ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; ENZYME STABILITY; HUMAN; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SRC HOMOLOGY DOMAIN; STRUCTURE ANALYSIS; X LINKED AGAMMAGLOBULINEMIA; X LINKED SEVERE COMBINED IMMUNODEFICIENCY;

DISEASE; ENZYME ACTIVATION; ENZYME STABILITY; HUMANS; MUTATION; PROTEIN-TYROSINE KINASES; SRC HOMOLOGY DOMAINS;

EID: 70649096122     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2009.10.001     Document Type: Review

References (49)

1. Pawson T., Gish G.D., and Nash P. SH2 domains, interaction modules and cellular wiring. Trends Cell Biol 11 (2001) 504-511
2. Liu B.A., Jablonowski K., Raina M., Arce M., Pawson T., and Nash P.D. The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. Mol Cell 22 (2006) 851-868
3. Li W., Young S.L., King N., and Miller W.T. Signaling properties of a non-metazoan Src kinase and the evolutionary history of Src negative regulation. J Biol Chem 283 (2008) 15491-15501. Interesting study that describes the conservation of the SH2-kinase unit in different organisms and its development as a regulator of Src activity.
4. Mayer B.J., Hirai H., and Sakai R. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. Curr Biol 5 (1995) 296-305
5. Kuriyan J., and Eisenberg D. The origin of protein interactions and allostery in colocalization. Nature 450 (2007) 983-990
6. Grucza R.A., Bradshaw J.M., Futterer K., and Waksman G. SH2 domains: from structure to energetics, a dual approach to the study of structure-function relationships. Med Res Rev 19 (1999) 273-293
7. Bradshaw J.M., and Waksman G. Calorimetric examination of high-affinity Src SH2 domain-tyrosyl phosphopeptide binding: dissection of the phosphopeptide sequence specificity and coupling energetics. Biochemistry 38 (1999) 5147-5154
8. Bradshaw J.M., Mitaxov V., and Waksman G. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase. J Mol Biol 293 (1999) 971-985
9. Songyang Z., Shoelson S.E., Chaudhuri M., Gish G., Pawson T., Haser W.G., King F., Roberts T., Ratnofsky S., Lechleider R.J., et al. SH2 domains recognize specific phosphopeptide sequences. Cell 72 (1993) 767-778
10. Machida K., Thompson C.M., Dierck K., Jablonowski K., Karkkainen S., Liu B., Zhang H., Nash P.D., Newman D.K., Nollau P., et al. High-throughput phosphotyrosine profiling using SH2 domains. Mol Cell 26 (2007) 899-915
11. Hu J., and Hubbard S.R. Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins. J Biol Chem 280 (2005) 18943-18949
12. Xu W., Harrison S.C., and Eck M.J. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385 (1997) 595-602
13. Xu W., Doshi A., Lei M., Eck M.J., and Harrison S.C. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol Cell 3 (1999) 629-638. Identification of the mechanisms leads to Src inactivation by the N-terminal SH2 and SH3 domain.
14. Sicheri F., Moarefi I., and Kuriyan J. Crystal structure of the Src family tyrosine kinase Hck. Nature 385 (1997) 602-609
15. Okada M., and Nakagawa H. A protein tyrosine kinase involved in regulation of pp60c-src function. J Biol Chem 264 (1989) 20886-20893
16. Young M.A., Gonfloni S., Superti-Furga G., Roux B., and Kuriyan J. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation. Cell 105 (2001) 115-126
17. Arold S.T., Ulmer T.S., Mulhern T.D., Werner J.M., Ladbury J.E., Campbell I.D., and Noble M.E. The role of the Src homology 3-Src homology 2 interface in the regulation of Src kinases. J Biol Chem 276 (2001) 17199-17205
18. Cowan-Jacob S.W., Fendrich G., Manley P.W., Jahnke W., Fabbro D., Liebetanz J., and Meyer T. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation. Structure 13 (2005) 861-871. This paper reports the active conformation of Src revealing a SH2 domain that forms no interaction with the active Scr kinase domain.
19. Bernado P., Perez Y., Svergun D.I., and Pons M. Structural characterization of the active and inactive states of Src kinase in solution by small-angle X-ray scattering. J Mol Biol 376 (2008) 492-505
20. Nagar B., Hantschel O., Young M.A., Scheffzek K., Veach D., Bornmann W., Clarkson B., Superti-Furga G., and Kuriyan J. Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112 (2003) 859-871
21. Hantschel O., Nagar B., Guettler S., Kretzschmar J., Dorey K., Kuriyan J., and Superti-Furga G. A myristoyl/phosphotyrosine switch regulates c-Abl. Cell 112 (2003) 845-857
22. Schindler T., Bornmann W., Pellicena P., Miller W.T., Clarkson B., and Kuriyan J. Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase. Science 289 (2000) 1938-1942
23. Deindl S., Kadlecek T.A., Brdicka T., Cao X., Weiss A., and Kuriyan J. Structural basis for the inhibition of tyrosine kinase activity of ZAP-70. Cell 129 (2007) 735-746. Report of the structure of the Zap70 inactive state suggests a mechanism of Zap70 activation by ICAM.
24. Zhang Y., Oh H., Burton R.A., Burgner J.W., Geahlen R.L., and Post C.B. Tyr130 phosphorylation triggers Syk release from antigen receptor by long-distance conformational uncoupling. Proc Natl Acad Sci U S A 105 (2008) 11760-11765
25. Xu B., and Miller W.T. Src homology domains of v-Src stabilize an active conformation of the tyrosine kinase catalytic domain. Mol Cell Biochem 158 (1996) 57-63
26. Sondhi D., and Cole P.A. Domain interactions in protein tyrosine kinase Csk. Biochemistry 38 (1999) 11147-11155
27. Shekhtman A., Ghose R., Wang D., Cole P.A., and Cowburn D. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis. J Mol Biol 314 (2001) 129-138
28. Cole P.A., Shen K., Qiao Y., and Wang D. Protein tyrosine kinases Src and Csk: a tail's tale. Curr Opin Chem Biol 7 (2003) 580-585
29. Ogawa A., Takayama Y., Sakai H., Chong K.T., Takeuchi S., Nakagawa A., Nada S., Okada M., and Tsukihara T. Structure of the carboxyl-terminal Src kinase, Csk. J Biol Chem 277 (2002) 14351-14354. This paper reports the structure of active Csk revealing interactions of the kinase-SH2 linker region with the αC helix.
30. Marquez J.A., Smith C.I., Petoukhov M.V., Lo Surdo P., Mattsson P.T., Knekt M., Westlund A., Scheffzek K., Saraste M., and Svergun D.I. Conformation of full-length Bruton tyrosine kinase (Btk) from synchrotron X-ray solution scattering. EMBO J 22 (2003) 4616-4624. This study reports an interesting low-resolution model of an active full-length Tec family member.
31. Joseph R.E., Min L., and Andreotti A.H. The linker between SH2 and kinase domains positively regulates catalysis of the Tec family kinases. Biochemistry 46 (2007) 5455-5462
32. Guo S., Wahl M.I., and Witte O.N. Mutational analysis of the SH2-kinase linker region of Bruton's tyrosine kinase defines alternative modes of regulation for cytoplasmic tyrosine kinase families. Int Immunol 18 (2006) 79-87
33. Radtke S., Haan S., Jorissen A., Hermanns H.M., Diefenbach S., Smyczek T., Schmitz-Vandeleur H., Heinrich P.C., Behrmann I., and Haan C. The Jak1 SH2 domain does not fulfill a classical SH2 function in Jak/STAT signaling but plays a structural role for receptor interaction and up-regulation of receptor surface expression. J Biol Chem 280 (2005) 25760-25768
34. Haan C., Kreis S., Margue C., and Behrmann I. Jaks and cytokine receptors - an intimate relationship. Biochem Pharmacol 72 (2006) 1538-1546
35. Nagar B., Hantschel O., Seeliger M., Davies J.M., Weis W.I., Superti-Furga G., and Kuriyan J. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase. Mol Cell 21 (2006) 787-798
36. Filippakopoulos P., Kofler M., Hantschel O., Gish G.D., Grebien F., Salah E., Neudecker P., Kay L.E., Turk B.E., Superti-Furga G., et al. Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell 134 (2008) 793-803. First structural report of an active Fes kinase revealing the mechanisms by which the SH2 domain stabilizes the kinase active state. The paper provides also a comparison and mutational analysis with active Abl.
37. Iacob R.E., Pene-Dumitrescu T., Zhang J., Gray N.S., Smithgall T.E., and Engen J.R. Conformational disturbance in Abl kinase upon mutation and deregulation. Proc Natl Acad Sci U S A 106 (2009) 1386-1391
38. Stone J.C., Atkinson T., Smith M., and Pawson T. Identification of functional regions in the transforming protein of Fujinami sarcoma virus by in-phase insertion mutagenesis. Cell 37 (1984) 549-558. This paper reports the SH2 domain for the first time as an activating motif in tyrosine kinases.
39. Sadowski I., Stone J.C., and Pawson T. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol Cell Biol 6 (1986) 4396-4408
40. Weinmaster G., Zoller M.J., Smith M., Hinze E., and Pawson T. Mutagenesis of Fujinami sarcoma virus: evidence that tyrosine phosphorylation of P130gag-fps modulates its biological activity. Cell 37 (1984) 559-568
41. Vihinen M., Nilsson L., and Smith C.I. Structural basis of SH2 domain mutations in X-linked agammaglobulinemia. Biochem Biophys Res Commun 205 (1994) 1270-1277
42. Richardson C.J., Gao Q., Mitsopoulous C., Zvelebil M., Pearl L.H., and Pearl F.M. MoKCa database - mutations of kinases in cancer. Nucleic Acids Res 37 (2009) D824-831
43. Matsuda S., Suzuki-Fujimoto T., Minowa A., Ueno H., Katamura K., and Koyasu S. Temperature-sensitive ZAP70 mutants degrading through a proteasome-independent pathway. Restoration of a kinase domain mutant by Cdc37. J Biol Chem 274 (1999) 34515-34518
44. Candotti F., Oakes S.A., Johnston J.A., Giliani S., Schumacher R.F., Mella P., Fiorini M., Ugazio A.G., Badolato R., Notarangelo L.D., et al. Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood 90 (1997) 3996-4003
45. Lappalainen I., Thusberg J., Shen B., and Vihinen M. Genome wide analysis of pathogenic SH2 domain mutations. Proteins 72 (2008) 779-792. This paper provides a comprehensive overview of disease-causing mutations in Btk.
46. Fiorini M., Franceschini R., Soresina A., Schumacher R.F., Ugazio A.G., Rossi P., Plebani A., and Notarangelo L.D. BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia. Hum Mutat 23 (2004) 286
47. Tzeng S.R., Pai M.T., Lung F.D., Wu C.W., Roller P.P., Lei B., Wei C.J., Tu S.C., Chen S.H., Soong W.J., et al. Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia. Protein Sci 9 (2000) 2377-2385
48. Hashimoto S., Tsukada S., Matsushita M., Miyawaki T., Niida Y., Yachie A., Kobayashi S., Iwata T., Hayakawa H., Matsuoka H., et al. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Blood 88 (1996) 561-573
49. Huck K., Feyen O., Niehues T., Ruschendorf F., Hubner N., Laws H.J., Telieps T., Knapp S., Wacker H.H., Meindl A., et al. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest 119 (2009) 1350-1358. First identification of a disease-causing mutation in the SH2 domain of Itk.